..In the current study we characterized these different subgroups in more detail, with a specific focus on the fourth divergent tumour subgroup (r4)...

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

J RyanDepartment of Molecular and Cellular Therapeutics, Cancer Genetics Research Group, Royal College of Surgeons in Ireland, York House, York Street, Dublin 2, IrelandBr J Cancer 107:967-76. 2012

..The aim of this study was to explore the independent association of miR-204 with survival in a neuroblastoma cohort, and to investigate the phenotypic effects mediated by miR-204 expression in neuroblastoma...